Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey
Authors:
- 1 August 2021
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 30 (1) , 511-519
Abstract
Purpose Scan-associated anxiety (‘scanxiety’) is a problem for people with advanced cancer. We aimed to determine the prevalence, severity and associations of scanxiety in this population. Methods People with advanced cancer and a computed tomography scan within the last 4 months completed a multicentre survey including self-rated presence (yes/no) and severity (distress thermometer, 0–10) of scanxiety, state anxiety (STAI-6), clinical anxiety and depression (HADS), and fear of progression (FOP-Q-SF). Associations with scanxiety were evaluated. Results There were 222 participants: mean age 64 years (range 26 to 91), female (61%), most common cancer types (breast 37%, lung 19%, colorectal 16%) and > 1 year since cancer diagnosis (82%). Sixty-two percent had a scan within the last month, and 70% reported waiting > 2 days for the result. Over half (55%) of participants experienced scanxiety. On multivariable analysis, scanxiety was more prevalent in participants who were younger (mean age 62 years with v 66 years without scanxiety, p = 0.02) and more remote (v major city, OR 2.6, p = 0.04). Among participants with scanxiety, the mean severity score was 6 (range 1–10) with peak severity occurring when waiting for scan results. On multivariable analysis, scanxiety was 1.2 points higher in participants who had been diagnosed within the past year (v > 1 year, p = 0.04) and was higher in participants who had higher STAI-6 scores (β = 0.06, p = 0.004). Conclusion Scanxiety is common and can be severe. Strategies to reduce scanxiety are needed.Keywords
This publication has 17 references indexed in Scilit:
- Depression and anxiety in patients with cancerBMJ, 2018
- New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer centerPatient Preference and Adherence, 2017
- Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”Lung Cancer, 2016
- Beeinträchtigungen der Meinungsäußerungsfreiheit durch die Zensur des Internets in China und im IranJahrbuch Menschenrechte, 2011
- Can This Patient Read and Understand Written Health Information?JAMA, 2010
- Progredienzangst bei Brustkrebspatientinnen - Validierung der Kurzform des Progredienzangstfragebogens PA-F-KF/ Fear of progression in breast cancer patients – validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)Zeitschrift Für Psychosomatische Medizin Und Psychotherapie, 2006
- Fear of progression in chronic diseasesJournal of Psychosomatic Research, 2005
- Anxiety and Anxiety Disorders2001
- The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)British Journal of Clinical Psychology, 1992
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983